# FDA Inspection 1307176 - SCA Pharmaceuticals, LLC - March 13, 2026

Source: https://www.keypedia.com/records/fda_inspections/sca-pharmaceuticals-llc/773b2600-60d4-4309-a9a0-a301b9a67212
Source feed: FDA_Inspections

> FDA Inspection 1307176 for SCA Pharmaceuticals, LLC on March 13, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1307176
- Company Name: SCA Pharmaceuticals, LLC
- Inspection Date: 2026-03-13
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New England District Office

## Related Documents

- [FDA Inspection 1252093 - 2024-12-20](https://www.keypedia.com/records/fda_inspections/sca-pharmaceuticals-llc/5b183fe0-2abd-41cf-9bcd-aa227ebda39a)
- [FDA Inspection 1221018 - 2023-10-20](https://www.keypedia.com/records/fda_inspections/sca-pharmaceuticals-llc/8ed46b4e-f317-4436-8ba7-6ec1a985a96b)

Company: https://www.keypedia.com/companies/sca-pharmaceuticals-llc/96e2ad34-fa1e-4fb7-a281-1aeff351cecc

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144